0 items USD 0.00Search
Your search for "chronic hepatitis C" gave back 4982 results.
Recombinant human interferon α1b for injection is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market size was valued at US$ million in 2023. With growing demand in downstream...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Diammonium Glycyrrhizinate for Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Diammonium Glycyrrhizinate for Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during...
Catalog:
GIR
June 2023
Price: USD 4,480.00
According to our (Global Info Research) latest study, the global Diammonium Glycyrrhizinate for Injection market size was valued at USD million in...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Diammonium Glycyrrhizinate is used in the treatment of acute and chronic viral hepatitis with elevated glutamylaminotransferase. It can improve the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Hepatic Encephalopathy Therapeutics market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Hepatitis C Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Hepatitis C Drugs is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
